LIFESEQUENCING

• In 2007, the company acquired Roche's 454 Genome Sequencer FLX platform, becoming the first installed and operating system in Spain for mass sequencing.
• Its staff has participated in numerous trainings and has a long experience in this type of sequencing, which has allowed it to adapt quickly to other 2nd generation sequencing platforms.
• It has the latest generation platforms such as FLX +, Illumina Hiseq, SOLID 5500xl and Ion Torrent PGM, which allow them to select the best equipment for their clients' objectives.  Currently it can address both de novo genome projects and re-sequencing projects in a more competitive fashion.
• The organisation, through collaborations with bio-informatics centres at the highest level, has allowed it to offer a high quality bio-informatics service.
• Since 2010, it has an in-house bio-informatics analysis department, headed by a specialist who has had numerous post-doctoral posts and is an expert in bio-informatics.

INNOVATIVE ASPECTS

• Knowledge and Management of ultra-sequencing technology.
• Development of applications through R+D + I.
• Knowledge Management systems.

COMPETITIVE ADVANTAGES

• Personalised advice.
• Last generation approach.
• High qualification of personnel.
• Integral service.

The genomics services in which Lifesequencing has great experience, focus on three areas:

• Genomic Studies:
  • Sequencing of de novo genomes.
  • Re-sequencing of genomes.
  • Sequencing of BACs/vectors.
  • Metagenomics
  • Taxonomic identification of microbiomes.
  • Capture of specific intronic or exonic zones
• Transcriptomic studies:
  • RNA-Seq/transcriptomics of genomes or tissues.
  • Meta-transcriptomic.
  • Small RNAs (microRNA, non-coding RNA).
• Gene regulation studies:
  • Methylation
  • Chip-Seq.

• Various industrial sectors (agriculture, livestock and chemical-pharmaceutical industries).
• Public or private research centres related to DNA sequencing.